Clinical trial Recruiting at 1 site Interventional Ages 21 to 85

Comparing Ultra High-Resolution CT to Conventional CT for Heart Disease

Official title: Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study

Run by Johns Hopkins University · NCT06170541 · Data updated 2026-11-12

This study is testing whether a new type of heart scan called Ultra High-Resolution CT can find heart disease better than the regular CT scan in people who are at lower risk.

Quick facts

Study typeInterventional
Ages21 Years to 85 Years
SexAll
Enrollment140 (estimated)
SponsorJohns Hopkins University
Academic / other
Drugs / interventionsradiation
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedApril 5, 2021
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedApril 13, 2026
Trial IDNCT06170541 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21-85 with a clinical history suggestive of coronary heart disease referred for further evaluation via CT angiography.

Probably not a fit

Patients with known allergies to iodinated contrast media or severe heart conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in identifying obstructive coronary heart disease (CHD) in a lower-risk population. Participants will undergo a single scan using UHR-CT, which allows for the reconstruction of conventional resolution images from the same data, minimizing radiation exposure and scan time. The primary goal is to gather preliminary data to support the hypothesis that UHR-CT is superior in detecting CHD. This approach aims to justify the broader implementation of UHR-CT technology in clinical practice.

Why it matters

Potential benefit: If successful, this study could lead to improved noninvasive detection of coronary heart disease, enhancing patient outcomes.

How similar studies have gone: While the specific use of UHR-CT in this context is novel, similar studies have shown promise in improving imaging techniques for cardiovascular conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 21-85 years
* Clinical history suggestive of CHD who are referred by their primary cardiologist for further evaluation via Computed tomography angiography (CTA) will be asked to participate.
* Women of child bearing potential must demonstrate a negative pregnancy test within 24 hours of the study CTA.
* Ability to understand and willingness to sign the Informed Consent Form.

Exclusion Criteria:

* Known allergy to iodinated contrast media.
* History of multiple myeloma or previous organ transplantation
* Elevated serum creatinine (\> 1.5mg/dl) OR calculated creatinine clearance of \< 60 ml/min (using the Cockcroft-Gault formula
* Atrial fibrillation or uncontrolled tachyarrhythmia, or advanced atrioventricular block (second or third degree heart block)
* Evidence of severe symptomatic heart failure (NYHA Class III or IV);
* Known or suspected moderate or severe aortic stenosis
* History of prior percutaneous coronary intervention (PCI) in one or more vessel or history of coronary arterial bypass grafting (CABG)
* Suspected acute coronary syndrome
* Presence of any other history or condition that the investigator feels would be problematic

Where it's running

  • Johns Hopkins School of Medicine
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Joao Lima, Professor — Md
  • Study coordinator: Joao Lima, Professor
  • Email: jlima@jhmi.edu
  • Phone: 4106141284

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.